• HOME
  • About us
  • History

History

We are constantly moving forward with our R&D and innovation.

2022
  • Breast Cancer Kit, CE approval
  • Lung Cancer Kit, CE approval
2020
  • Selection of Excellent Research Institute (Korea Industrial Technology Promotion Association)
2018
  • Expand sales and marketing around the world
  • Completed the development of screening product for stage 0~1 lung cancer
  • GMP certification
  • ISO 13485 certification
  • Gangwon-do promising company certification
  • Venture company certification
  • Winner of Global Healthcare Awards in Korea
2017
  • Established mass production facility for protein products
  • CE certification and KFDA certification for cardiovascular products
  • Winner of award the grand prize of technology by Gangwon-do
  • Winner of award for the promotion of health and medical technology 2017
2016
  • INNO-BIZ certification
2014
  • Winner the best new technology award in industrial technology
  • Winner of the 2014 Gangwon New technology award
2012~2016
  • Development of DAGON technology, the core technology of protein products
2012
  • Obtained medical device manufacturing license
2010
  • Obtained pharmaceutical manufacturing license
  • Established R&D center
2008~2011
  • CE certification and KFDA certification for HPV 9G DNA kit
2000~2008
  • Core Technology development and prototype production

Biometrix Technology Co., Ltd.Address 2-2ho BioVenture Plaza, 56 Soyanggang-ro, Chuncheon-si, Gangwon-do, 24232, Korea

CEO: Taisun KimCustomer Center Tel. 033-258-6098Fax. 033-258-6099E-mail. worldbiz@bmtchip.com

© 2019. Biometrix Technology Co., Ltd. All rights reserved.